FRAuthor Archives: goodcorporation
Deregulation and the anti-corruption agenda
In many circles it is widely held that business and regulation are polar opposites: the...
An open relationship
Moves to boost transparency in the relationships between healthcare professionals and pharmaceutical companies come into...
Why do good companies behave badly?
The debate began by asking what we mean by a ‘good’ company? In English, ‘good’...
Are businesses doing enough to minimise human rights abuses and will the Modern Slavery Act make a difference?
Frances House, Deputy Executive Director of the Institute for Human Rights and Business (IHRB) introduced...
A Rotten Heart
Shockwaves from the Toshiba accounting scandal were felt way beyond the company. The scandal dealt...
Should boards and investors pay more attention to ethical culture
The emissions scandal at Volkswagen reveals how costly a lapse in ethical judgement can be....
Can the pharma industry achieve transparency with self-regulated disclosure?
Karen Borrer, Head of Reputation at the Association of the British Pharmaceutical Industry (ABPI), opened...
Big Businesses face Big Risks: how should global companies tackle the problem?
The debate began with the suggestion that one way to minimise the risks is for...
Update Autumn 2015
Leo Martin led delegates at London’s LegalConfex in September through the Anti-Corruption Boot Camp with...
Is compliance keeping you up at night?
Breaching regulations is an expensive business as Volkswagen has discovered. Within hours of the revelation...
Will the Yates Memo have an impact beyond the US border?
Earlier this month the Department of Justice (DOJ) issued a memorandum from the Deputy Attorney...
Modern slavery and the supply chain
In March 2015, the Modern Slavery Act received Royal Assent in the UK. This poses...
